moxifloxacin has been researched along with prednisolone in 41 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (prednisolone) | Trials (prednisolone) | Recent Studies (post-2010) (prednisolone) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 34,414 | 3,302 | 7,141 |
| Protein | Taxonomy | moxifloxacin (IC50) | prednisolone (IC50) |
|---|---|---|---|
| Glucocorticoid receptor | Homo sapiens (human) | 0.0278 | |
| Progesterone receptor | Homo sapiens (human) | 2.08 | |
| Glucocorticoid receptor | Rattus norvegicus (Norway rat) | 0.0565 | |
| Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 0.016 | |
| Mineralocorticoid receptor | Homo sapiens (human) | 0.0322 | |
| Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 0.016 | |
| Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 0.016 | |
| Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 0.016 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (19.51) | 29.6817 |
| 2010's | 29 (70.73) | 24.3611 |
| 2020's | 4 (9.76) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Cortez, MA; Escaf, L; Escaf, S; Giuliari, GP; Vidal, C | 1 |
| Acharya, NR; Chen, A; Lietman, TM; Mahalakshmi, R; McLeod, S; Prajna, L; Srinivasan, M; Whitcher, JP | 1 |
| Choi, HW; Chung, SH; Moon, SW; Nam, KH | 1 |
| Neiberg, MN; Sowka, J | 1 |
| Bhadresa, S; Coon, DJ; Lawrence, MS; Magiera, D; Struharik, M; Ward, KW | 1 |
| Bu, DF; Chen, XX; Li, WW; Tu, P; Wang, Y; Yu, J | 1 |
| Akova, YA; Altinors, DD; Bayar, SA; Kucukerdonmez, C | 1 |
| Becker, J; Chatzikyrkou, C; Clajus, C; Hafer, C; Hamwi, I; Kielstein, JT | 1 |
| Agarwal, T; Jhanji, V; Sharma, N; Vajpayee, RB | 1 |
| Feilmeier, MR; Ide, T; Piccoli, FV; Schmitt, AJ; Yoo, SH | 1 |
| Carlson, EM; Meskin, SW | 1 |
| Acharya, NR; Glidden, DV; Hong, KC; Lalitha, P; Lee, SM; Lietman, TM; Mascarenhas, J; McLeod, SD; Oldenburg, CE; Rajaraman, R; Ravindran, M; Ray, KJ; Srinivasan, M; Zegans, ME | 2 |
| Acharya, NR; Glidden, D; Lalitha, P; Lietman, TM; Mascarenhas, J; McLeod, SD; Oldenburg, CE; Rajaraman, R; Ravindran, M; Ray, KJ; Srinivasan, M; Sy, A; Zegans, ME | 1 |
| Acharya, NR; Lalitha, P; Lietman, TM; Mascarenhas, J; McLeod, SD; Oldenburg, CE; Priya, JL; Rajaraman, R; Ravindran, M; Ray, KJ; Srinivasan, M; Sy, A; Zegans, ME | 1 |
| Acharya, NR; Esterberg, EJ; Glaser, TS; Lietman, TM; McLeod, SD; Oldenburg, CE; Ray, KJ; Saravanan, S; See, CW; Srinivasan, M; Tu, EY; Zegans, ME | 1 |
| Ben Eliahu, S; Bronshtein, R; Kleinmann, G; Lipnitzki, I; Marcovich, AL | 1 |
| Acharya, NR; Greninger, DA; Keenan, JD; Lietman, TM; Mascarenhas, J; McClintic, SM; Srinivasan, M | 1 |
| Acharya, NR; Geetha, M; Glidden, D; Karpagam, R; Lietman, TM; McLeod, SD; Oldenburg, CE; Prajna, L; Ray, KJ; Srinivasan, M; Sun, CQ | 1 |
| Acharya, NR; Bharathi, MJ; Glidden, DV; Lalitha, P; Lietman, TM; Manikandan, P; Mascarenhas, J; Nardone, N; Oldenburg, CE; Rajaraman, R; Ravindran, M; Ray, KJ; Srinivasan, M | 1 |
| Johnson, PD; Trevillyan, JM | 1 |
| Acharya, NR; Borkar, DS; Lalitha, P; Lietman, TM; Mascarenhas, J; McLeod, SD; Oldenburg, CE; Porco, TC; Rajaraman, R; Ravindran, M; Ray, KJ; Srinivasan, M; Zegans, ME | 1 |
| Acharya, NR; Glidden, DV; Lalitha, P; Lietman, TM; Mascarenhas, J; McLeod, SD; O'Brien, KS; Oldenburg, CE; Porco, TC; Rajaraman, R; Ravindran, M; Ray, KJ; Srinivasan, M; Whitcher, JP; Zegans, ME | 1 |
| Acharya, NR; Keenan, JD; Lalitha, P; Lietman, TM; Mascarenhas, J; Rajaraman, R; Ravindran, M; Ray, KJ; Srinivasan, M; Zegans, ME | 1 |
| Acharya, NR; Keenan, JD; Lalitha, P; Lietman, TM; Mascarenhas, J; McClintic, SM; O'Brien, KS; Oldenburg, CE; Prajna, NV; Rajaraman, R; Ray, KJ; Srinivasan, M | 1 |
| Acharya, NR; Glidden, DV; Lietman, TM; Mascarenhas, J; McLeod, SD; Oldenburg, CE; Rajaraman, R; Ravindran, M; Ray, KJ; Srinivasan, M; Sun, CQ; Zegans, ME | 1 |
| Estrela, C; Puente, CG; Regalado Farreras, DC | 1 |
| Cherof, AM; Kahook, MY; Seibold, LK; SooHoo, JR | 1 |
| Pujari, A; Singh, R; Temkar, S; Urkude, J | 1 |
| Moussa, K; Schallhorn, JM; Shantha, J | 1 |
| Das, S; Sahoo, S | 1 |
| Abbas, SS; Abdelwahab, MH; Hegazy, MA; Hendawy, HAM; Weshahy, SA | 1 |
| Donnenfeld, ED; Hovanesian, JA | 1 |
| Gümüş, G; Kara, N; Karatas Durusoy, G; Öcal, MC | 1 |
| Baratz, KH; Farazdaghi, MK; Patel, SV; Tailor, PD | 1 |
2 review(s) available for moxifloxacin and prednisolone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Mooren's-type ulceration associated with severe hidradenitis suppurativa: a case report and literature review.
Topics: Amnion; Antibodies, Monoclonal; Aza Compounds; Conjunctiva; Corneal Perforation; Corneal Ulcer; Dermatologic Agents; Disease Progression; Doxycycline; Drug Therapy, Combination; Fluoroquinolones; Hidradenitis Suppurativa; Humans; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Middle Aged; Moxifloxacin; Prednisolone; Prednisone; Quinolines; Severity of Illness Index; Treatment Outcome; Visual Acuity | 2011 |
14 trial(s) available for moxifloxacin and prednisolone
| Article | Year |
|---|---|
Does in vitro susceptibility predict clinical outcome in bacterial keratitis?
Topics: Anti-Infective Agents; Aza Compounds; Bacteria; Corneal Ulcer; Disease Susceptibility; Eye Infections, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Pilot Projects; Prednisolone; Quinolines; Randomized Controlled Trials as Topic; Retrospective Studies; Treatment Outcome; Visual Acuity | 2008 |
The steroids for corneal ulcers trial: study design and baseline characteristics.
Topics: Administration, Topical; Adult; Anti-Infective Agents; Aza Compounds; Bacteria; Cornea; Corneal Ulcer; Double-Blind Method; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Glucocorticoids; Humans; Male; Middle Aged; Moxifloxacin; Prednisolone; Quinolines; Research Design; Treatment Outcome; Visual Acuity | 2012 |
Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT).
Topics: Administration, Topical; Adult; Anti-Infective Agents; Aza Compounds; Bacteria; Cornea; Corneal Ulcer; Double-Blind Method; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Glucocorticoids; Humans; Male; Middle Aged; Moxifloxacin; Prednisolone; Quinolines; Treatment Outcome; Visual Acuity | 2012 |
Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment.
Topics: Adult; Anti-Infective Agents; Aza Compounds; Corneal Ulcer; Double-Blind Method; Eye Infections, Bacterial; Female; Fluoroquinolones; Follow-Up Studies; Glucocorticoids; Humans; Male; Middle Aged; Moxifloxacin; Prednisolone; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Treatment Outcome; Visual Acuity | 2012 |
Nocardia keratitis: clinical course and effect of corticosteroids.
Topics: Administration, Topical; Adult; Anti-Infective Agents; Aza Compounds; Corneal Ulcer; Double-Blind Method; Eye Infections, Bacterial; Female; Fluoroquinolones; Glucocorticoids; Humans; Male; Middle Aged; Moxifloxacin; Nocardia; Nocardia Infections; Polymerase Chain Reaction; Prednisolone; Quinolines; Treatment Outcome; Visual Acuity | 2012 |
Prior elicitation and Bayesian analysis of the Steroids for Corneal Ulcers Trial.
Topics: Administration, Topical; Anti-Infective Agents; Aza Compounds; Bayes Theorem; Corneal Ulcer; Double-Blind Method; Eye Infections, Bacterial; Fluoroquinolones; Glucocorticoids; Humans; Moxifloxacin; Ophthalmic Solutions; Prednisolone; Quinolines; Surveys and Questionnaires; Treatment Outcome; Visual Acuity | 2012 |
Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis.
Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Bacteria; Corneal Ulcer; Double-Blind Method; Drug Resistance, Bacterial; Eye Infections, Bacterial; Female; Fluoroquinolones; Glucocorticoids; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Nocardia; Nocardia Infections; Pneumococcal Infections; Prednisolone; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Streptococcus pneumoniae | 2013 |
Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis.
Topics: Administration, Topical; Anti-Infective Agents; Aza Compounds; Bacteria; Corneal Ulcer; Disease Susceptibility; Double-Blind Method; Eye Infections, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Ophthalmic Solutions; Prednisolone; Quinolines; Treatment Outcome; Visual Acuity | 2013 |
Emerging moxifloxacin resistance in Pseudomonas aeruginosa keratitis isolates in South India.
Topics: Anti-Bacterial Agents; Aza Compounds; Communicable Diseases, Emerging; Cornea; Corneal Ulcer; Double-Blind Method; Drug Resistance, Bacterial; Drug Therapy, Combination; Eye Infections, Bacterial; Fluoroquinolones; Glucocorticoids; Humans; India; Microbial Sensitivity Tests; Moxifloxacin; Prednisolone; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines | 2013 |
The steroids for corneal ulcers trial (SCUT): secondary 12-month clinical outcomes of a randomized controlled trial.
Topics: Administration, Topical; Adult; Anti-Bacterial Agents; Aza Compounds; Bacteria; Corneal Ulcer; Double-Blind Method; Eye Infections, Bacterial; Female; Fluoroquinolones; Glucocorticoids; Humans; Male; Middle Aged; Moxifloxacin; Nocardia; Nocardia Infections; Ophthalmic Solutions; Prednisolone; Quinolines; Treatment Outcome; Visual Acuity | 2014 |
Visual recovery in treated bacterial keratitis.
Topics: Adult; Aged; Anti-Bacterial Agents; Aza Compounds; Corneal Ulcer; Eye Infections, Bacterial; Female; Fluoroquinolones; Glucocorticoids; Humans; Male; Middle Aged; Moxifloxacin; Prednisolone; Quinolines; Recovery of Function; Visual Acuity | 2014 |
Visual outcomes in treated bacterial keratitis: four years of prospective follow-up.
Topics: Adult; Aged; Anti-Bacterial Agents; Aza Compounds; Corneal Ulcer; Double-Blind Method; Eye Infections, Bacterial; Female; Fluoroquinolones; Follow-Up Studies; Glucocorticoids; Humans; Male; Middle Aged; Moxifloxacin; Prednisolone; Prospective Studies; Quinolines; Regression Analysis; Visual Acuity | 2014 |
Early addition of topical corticosteroids in the treatment of bacterial keratitis.
Topics: Administration, Topical; Adult; Aza Compounds; Confidence Intervals; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Follow-Up Studies; Humans; Keratitis; Linear Models; Male; Middle Aged; Moxifloxacin; Multivariate Analysis; Prednisolone; Quinolines; Severity of Illness Index; Time Factors; Treatment Outcome | 2014 |
Intracameral dexamethasone 9% vs prednisolone acetate 1% in controlling postoperative pain and inflammation in patients undergoing cataract surgery.
Topics: Cataract; Cataract Extraction; Dexamethasone; Humans; Inflammation; Moxifloxacin; Ophthalmic Solutions; Pain, Postoperative; Phacoemulsification; Postoperative Complications; Prednisolone; Prospective Studies | 2022 |
25 other study(ies) available for moxifloxacin and prednisolone
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Ocular cysticercosis of the anterior segment.
Topics: Animals; Anterior Eye Segment; Aza Compounds; Child; Cysticercosis; Cysticercus; Drug Therapy, Combination; Eye Infections, Parasitic; Female; Fluoroquinolones; Humans; Moxifloxacin; Prednisolone; Quinolines; Uveitis, Anterior | 2007 |
Late-onset interface inflammation associated with wearing cosmetic lenses 18 months after laser in situ keratomileusis.
Topics: Adult; Aza Compounds; Contact Lenses; Corneal Edema; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Keratitis; Keratomileusis, Laser In Situ; Lasers, Excimer; Moxifloxacin; Myopia; Prednisolone; Quinolines; Surgical Flaps; Visual Acuity | 2008 |
Phlyctenular keratoconjunctivitis in a patient with Staphylococcal blepharitis and ocular rosacea.
Topics: Administration, Oral; Administration, Topical; Adult; Aza Compounds; Blepharitis; Cyclosporine; Doxycycline; Drug Therapy, Combination; Eye Infections, Bacterial; Fluoroquinolones; Humans; Keratoconjunctivitis; Male; Moxifloxacin; Ophthalmic Solutions; Prednisolone; Quinolines; Rosacea; Staphylococcal Infections | 2008 |
Exploration of the African green monkey as a preclinical pharmacokinetic model: oral pharmacokinetic parameters and drug-drug interactions.
Topics: Animals; Aza Compounds; Chlorocebus aethiops; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Evaluation, Preclinical; Erythromycin; Fluoroquinolones; Lidocaine; Mass Spectrometry; Models, Animal; Moxifloxacin; Pharmacokinetics; Phenytoin; Prednisolone; Propranolol; Quinolines; Species Specificity | 2009 |
Haemolytic anaemia following rituximab treatment in a patient with pemphigus vulgaris.
Topics: Adult; Anemia, Hemolytic; Anti-Infective Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Aza Compounds; Dermatologic Agents; Fluoroquinolones; Humans; Immunologic Factors; Male; Methotrexate; Moxifloxacin; Pemphigus; Prednisolone; Quinolines; Rituximab | 2009 |
Severe corneal changes following intravitreal injection of bevacizumab.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aza Compounds; Bevacizumab; Choroidal Neovascularization; Corneal Edema; Descemet Membrane; Dexamethasone; Female; Fluoroquinolones; Humans; Keratitis; Macular Degeneration; Male; Moxifloxacin; Prednisolone; Quinolines; Retrospective Studies; Visual Acuity | 2010 |
Biopsy proven acute interstitial nephritis after treatment with moxifloxacin.
Topics: Acute Disease; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Aza Compounds; Biopsy; Carcinoma, Non-Small-Cell Lung; Creatinine; Edema; Eosinophilia; Fluoroquinolones; Humans; Lung Neoplasms; Male; Moxifloxacin; Nephritis, Interstitial; Pneumonectomy; Pneumonia; Postoperative Complications; Prednisolone; Quinolines | 2010 |
Presumed corneal stromal graft rejection after deep anterior lamellar keratoplasty in a patient with systemic lupus erythematosis.
Topics: Adolescent; Aza Compounds; Cornea; Corneal Edema; Corneal Stroma; Corneal Transplantation; Drug Administration Schedule; Drug Therapy, Combination; Eyeglasses; Female; Fluoroquinolones; Glucocorticoids; Graft Rejection; Humans; Injections, Intravenous; Keratoconus; Lupus Erythematosus, Systemic; Methylprednisolone; Moxifloxacin; Ophthalmic Solutions; Postoperative Complications; Postoperative Period; Prednisolone; Quinolines; Time Factors; Ultrasonography; Visual Acuity | 2010 |
Interface blood after descemet stripping automated endothelial keratoplasty.
Topics: Administration, Topical; Aged, 80 and over; Aza Compounds; Blood Loss, Surgical; Descemet Stripping Endothelial Keratoplasty; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Hyphema; Intraoperative Complications; Iridectomy; Moxifloxacin; Prednisolone; Quinolines; Visual Acuity | 2011 |
Hydrophilic acrylic intraocular lens as a drug delivery system: influence of the presoaking time and comparison to intracameral injection.
Topics: Acrylic Resins; Animals; Anti-Bacterial Agents; Aqueous Humor; Aza Compounds; Chromatography, High Pressure Liquid; Drug Delivery Systems; Female; Fluoroquinolones; Gatifloxacin; Hydrophobic and Hydrophilic Interactions; Injections, Intraocular; Lens Implantation, Intraocular; Lenses, Intraocular; Male; Moxifloxacin; Prednisolone; Quinolines; Rabbits; Time Factors; Tissue Distribution | 2013 |
Improvement in corneal scarring following bacterial keratitis.
Topics: Adult; Aged; Aza Compounds; Cicatrix; Corneal Ulcer; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Ophthalmic Solutions; Pneumococcal Infections; Prednisolone; Pseudomonas Infections; Quinolines; Vision Disorders; Visual Acuity | 2013 |
Steroids control paradoxical worsening of Mycobacterium ulcerans infection following initiation of antibiotic therapy.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Aza Compounds; Buruli Ulcer; Debridement; Fluoroquinolones; Glucocorticoids; Humans; Male; Moxifloxacin; Mycobacterium ulcerans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prednisolone; Quinolines; Rifampin; Young Adult | 2013 |
Sodium hypochlorite chemical burn in an endodontist's eye during canal treatment using operating microscope.
Topics: Accidents, Occupational; Analgesics, Non-Narcotic; Anti-Bacterial Agents; Anti-Inflammatory Agents; Burns, Chemical; Corneal Ulcer; Cyclopentolate; Dentists; Eye Burns; Female; Fluoroquinolones; Follow-Up Studies; Humans; Ibuprofen; Loteprednol Etabonate; Microsurgery; Moxifloxacin; Mydriatics; Occupational Diseases; Prednisolone; Root Canal Irrigants; Root Canal Preparation; Sodium Hypochlorite; Therapeutic Irrigation; Young Adult | 2014 |
Endophthalmitis With Corneal Infiltrate After EX-PRESS Glaucoma Drainage Device Implantation.
Topics: Alkylating Agents; Anti-Bacterial Agents; Corneal Diseases; Device Removal; Drug Combinations; Endophthalmitis; Fluoroquinolones; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Glucocorticoids; Humans; Intraocular Pressure; Male; Middle Aged; Mitomycin; Moxifloxacin; Prednisolone | 2016 |
Child with hypopyon.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Ceftazidime; Corneal Perforation; Diagnosis, Differential; Endophthalmitis; Eye Hemorrhage; Fluoroquinolones; Humans; Infant; Male; Moxifloxacin; Prednisolone; Ultrasonography; Vancomycin | 2017 |
Blurry Vision and Eye Pain After Pterygium Surgery.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Eye Infections, Bacterial; Eye Pain; Female; Glucocorticoids; Humans; Indomethacin; Intraocular Pressure; Levofloxacin; Moxifloxacin; Ophthalmologic Surgical Procedures; Prednisolone; Pseudomonas aeruginosa; Pseudomonas Infections; Pterygium; Scleritis; Vision Disorders; Visual Acuity | 2018 |
The "stung" cornea - Retained insect sting on the corneal endothelium.
Topics: Administration, Ophthalmic; Adult; Anti-Bacterial Agents; Corneal Injuries; Endothelium, Corneal; Eye Foreign Bodies; Glucocorticoids; Humans; Insect Bites and Stings; Keratitis; Male; Moxifloxacin; Prednisolone; Slit Lamp Microscopy | 2020 |
Selective and Sensitive Chromatographic Methods for Determination of a Co-Formulated Binary Mixture in Antibacterial Eye Drops and Aqueous Humor in the Presence of Their Degradation Products and Potential Impurities.
Topics: Anti-Bacterial Agents; Aqueous Humor; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Moxifloxacin; Ophthalmic Solutions; Prednisolone; Reproducibility of Results | 2019 |
Cases of toxic anterior segment syndrome after primary pterygium surgery.
Topics: Anterior Eye Segment; Conjunctiva; Eye Diseases; Fibrin; Formaldehyde; Humans; Hyaluronic Acid; Moxifloxacin; Phacoemulsification; Postoperative Complications; Prednisolone; Pterygium; Syndrome | 2022 |
Oleander-Associated Keratitis and Uveitis.
Topics: Corneal Edema; Cyclopentolate; Female; Humans; Inflammation; Keratitis; Middle Aged; Moxifloxacin; Nerium; Prednisolone; Prednisone; Uveitis, Anterior | 2022 |